Omada Health, Inc. Increase (Decrease) in Contract with Customer, Asset
Omada Health, Inc. (OMDA) reported Increase (Decrease) in Contract with Customer, Asset of $2.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2026-08-07
- Omada Health, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2026-06-30 was $655.00K, a 193.72% increase year-over-year.
- Omada Health, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2026-03-31 was $2.20M, a 83.50% increase year-over-year.
- Omada Health, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2025-12-31 was $1.19M, a 23.16% decline year-over-year.
- Omada Health, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2025-09-30 was $896.00K, a 26.01% decline year-over-year.
- Omada Health, Inc. increase (decrease) in contract with customer, asset for fiscal 2025 was $3.51M, a 45.34% decline from fiscal 2024.
- Omada Health, Inc. increase (decrease) in contract with customer, asset for fiscal 2024 was $6.42M, a 73.61% increase from fiscal 2023.
- Omada Health, Inc. increase (decrease) in contract with customer, asset for fiscal 2023 was $3.70M.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2026-06-30 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.86M 10-Q · filed 2026-08-07 | $4.05M derived: sum of 3 quarters · filed 2026-08-07 | $4.94M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $2.20M 10-Q · filed 2026-05-08 | $3.39M derived: sum of 2 quarters · filed 2026-05-08 | $4.29M derived: sum of 3 quarters · filed 2026-05-08 | $4.51M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.09M derived: sum of 2 quarters · filed 2026-03-06 | $2.31M derived: sum of 3 quarters · filed 2026-08-07 | $3.51M 10-K · filed 2026-03-06 |
| 2025-09-30 | $896.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.12M derived: sum of 2 quarters · filed 2026-08-07 | $2.32M 10-Q · filed 2025-11-07 | $3.87M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.42M 10-Q · filed 2026-08-07 | $2.97M derived: sum of 3 quarters · filed 2026-08-07 | $4.18M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-08 | $2.75M derived: sum of 2 quarters · filed 2026-05-08 | $3.96M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.76M derived: sum of 2 quarters · filed 2026-03-06 | $6.42M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.87M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $3.66M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $3.70M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |